Jul 14, 2021
News & Events
Press Releases
Jul 13, 2021
Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas
Jul 9, 2021
Salarius Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference
Jun 15, 2021
Salarius Pharmaceuticals Announces New Clinical Trial to Study Seclidemstat in Hematologic Cancers
Events
NobleCon17: Panel Discussion on Targeted Cancer Therapies
During the Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference, Dr. Daniela Santiesteban, Director of Research and Business Development at Salarius Pharmaceuticals, will participate in a virtual panel discussion highlighting the future of targeted cancer therapies. The panel...
Biotech Showcase Digital
https://informaconnect.com/biotech-showcase/registration-options/
A.G.P.’s Virtual Healthcare Symposium
Salarius Pharmaceuticals to Report Third Quarter 2020 Financial Results
Conference Call Information: Interested participants and investors may access the conference call by dialing either: (833) 423-0481 (U.S.) (918) 922-2375 (international) Conference ID: 1277839
In the News
Houston Business Journal